HIGHLIGHTS
- who: Davide De Forni and collaborators from the Research Institute for Genetic and Human Therapy have published the Article: Synergistic drug combinations designed to fully suppress SARS-CoV-2 in the lung of COVID-19 patients, in the Journal: PLOS ONE of 22/03/2022
- what: The authors compare the activity of two drugs (Drug A and Drug B) as monotherapy or in combination. A clinical study submitted after the study had been submitted and published while the manuscript was under review found that the coadministration of RDV and AZI was associated with reduced risk . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.